Bausch Health Companies Inc
TSX:BHC

Watchlist Manager
Bausch Health Companies Inc Logo
Bausch Health Companies Inc
TSX:BHC
Watchlist
Price: 11.17 CAD -2.45% Market Closed
Market Cap: 4.1B CAD
Have any thoughts about
Bausch Health Companies Inc?
Write Note

Bausch Health Companies Inc
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bausch Health Companies Inc
Cash from Investing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Bausch Health Companies Inc
TSX:BHC
Cash from Investing Activities
-$402m
CAGR 3-Years
N/A
CAGR 5-Years
0%
CAGR 10-Years
-26%
Sundial Growers Inc
NASDAQ:SNDL
Cash from Investing Activities
-CA$24.8m
CAGR 3-Years
30%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Cronos Group Inc
TSX:CRON
Cash from Investing Activities
$420.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
Cash from Investing Activities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
K
Knight Therapeutics Inc
TSX:GUD
Cash from Investing Activities
-CA$3m
CAGR 3-Years
70%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Curaleaf Holdings Inc
CNSX:CURA
Cash from Investing Activities
-$114.7m
CAGR 3-Years
16%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Bausch Health Companies Inc
Glance View

Market Cap
4.1B CAD
Industry
Pharmaceuticals

Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. The company is headquartered in Laval, Quebec and currently employs 19,600 full-time employees. The firm is engaged in developing, manufacturing, and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment and aesthetics devices), which are marketed directly or indirectly in over 100 countries. Its segments include Bausch + Lomb, Salix, Ortho Dermatologics, International Rx and Diversified Products. The Bausch + Lomb segment consists of sales in the United States of Bausch + Lomb Vision Care, Consumer, Surgical and Ophthalmology Rx products. The Salix segment consists of sales in the United States of gastroenterology (GI) products. The Ortho Dermatologics segment consists of sales in the United States of Ortho Dermatologics (dermatological) products and global sales of Solta medical aesthetic devices.

BHC Intrinsic Value
111.27 CAD
Undervaluation 90%
Intrinsic Value
Price

See Also

What is Bausch Health Companies Inc's Cash from Investing Activities?
Cash from Investing Activities
-402m USD

Based on the financial report for Sep 30, 2024, Bausch Health Companies Inc's Cash from Investing Activities amounts to -402m USD.

What is Bausch Health Companies Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-26%

Over the last year, the Cash from Investing Activities growth was 81%.

Back to Top